Xi'an, China

Jingyi Li

USPTO Granted Patents = 20 

Average Co-Inventor Count = 11.9

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Xi+3 an, CN (2022 - 2023)
  • Xi'an, CN (2020 - 2024)

Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

20 patents (USPTO):

Title: The Innovative Contributions of Jingyi Li

Introduction

Jingyi Li is a prominent inventor based in Xi'an, China, recognized for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 20 patents, Jingyi has focused his research on developing compounds that promise to make a substantial impact on public health, particularly in combating viral diseases.

Latest Patents

Among his latest innovations is the patent for a 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound, which effectively inhibits the activity of coronavirus 3CL protease. This invention is particularly notable for its potential use in the treatment of COVID-19, as it blocks the replication and transcription of SARS-CoV-2 viruses in patients. The compound not only demonstrates high in-vitro safety but also holds promise for future anti-SARS-CoV-2 drug development.

Another significant patent involves pleuromutilin cinnamic acid ester compounds, which have shown effectiveness against antibiotic-resistant infections. These compounds, characterized by their varying chemical structures, exhibit properties that can help mitigate the growing global concern of antibiotic resistance.

Career Highlights

Jingyi Li has built an esteemed career within the realms of academia and the pharmaceutical industry. He has been affiliated with Shaanxi University of Science and Technology, contributing to research and innovation in medicinal chemistry. Additionally, he worked with Shaanxi Panlong Pharmaceutical Co., Ltd., where he further pursued the development of therapeutic compounds and collaborated with other professionals in the field.

Collaborations

Throughout his career, Jingyi has collaborated with notable colleagues such as Liang Xin and Chengyuan Liang. These partnerships have played a vital role in advancing his research efforts and enhancing the efficacy of the compounds he has developed.

Conclusion

Jingyi Li's contributions to the field of medicinal chemistry underscore his commitment to innovation and public health. His patents reflect a deep understanding of the challenges posed by viral infections and antibiotic resistance, positioning him as a key figure in the ongoing search for effective therapeutic solutions. As research in these fields continues to evolve, Jingyi's work will undoubtedly remain influential in shaping future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…